Do sputum eosinophils and ECP relate to the severity of asthma?

There is much evidence that eosinophils play an important role in bronchial epithelial damage in asthma by releasing cationic proteins. However, the extent to which eosinophil inflammation relates to indices of asthma severity in chronic stable asthma is still a matter of debate. We studied 46 clinically stable patients with mild to severe chronic asthma (forced expiratory volume in one second (FEV1) 50-126% of predicted value). The clinical severity of asthma was graded from 1 to 4 according to the Aas scoring system. Twelve normal subjects were also studied as controls. Induction of sputum was performed by hypertonic saline to determine differential cell count, and eosinophil cationic protein (ECP) by the so-called "plug technique". The concentration of ECP was measured by a fluoroimmunoassay. Bronchial hyperresponsiveness was recorded by inhaling progressive concentrations of histamine, and the concentration that caused a 20% decrease in FEV1 (PC20) was calculated. Sputum eosinophils (range 0-61%), sputum ECP (range 24-10,800 microg x L[-1]) and serum ECP (range 4-61 microg x L[-1]) were significantly greater in asthmatics than in normal subjects, and distinguished the most severe group with the highest Aas score from the others. Sputum eosinophils and sputum ECP were strongly related to each other. The relationships between sputum or serum ECP and PC20 (range 0.016-7.5 mg x mL[-1]), and between sputum ECP and FEV1 were found to be weak. In conclusion, sputum outcomes of eosinophil activation and serum eosinophilic cationic protein appear to be useful indicators of disease. They do not accurately reflect current clinical or functional indices of asthma severity in chronic stable patients, and might therefore provide complementary data disease monitoring.

This article has been cited by other articles:

				T F Leung, G W K Wong, F W S Ko, C W K Lam, and T F Fok Clinical and atopic parameters and airway inflammatory markers in childhood asthma: a factor analysis Thorax, October 1, 2005; 60(10): 822 - 826. [Abstract] [Full Text] [PDF]

				S. Cianchetti, E. Bacci, L. Ruocco, M.L. Bartoli, M. Ricci, T. Pavia, F.L. Dente, A. Di Franco, B. Vagaggini, and P.L. Paggiaro Granulocyte markers in hypertonic and isotonic saline-induced sputum of asthmatic subjects Eur. Respir. J., December 1, 2004; 24(6): 1018 - 1024. [Abstract] [Full Text] [PDF]

				P. Godon, L-P. Boulet, J-L. Malo, A. Cartier, and C. Lemiere Assessment and evaluation of symptomatic steroid-naive asthmatics without sputum eosinophilia and their response to inhaled corticosteroids Eur. Respir. J., December 1, 2002; 20(6): 1364 - 1369. [Abstract] [Full Text] [PDF]

				R.E. Louis, D. Cataldo, M.G. Buckley, J. Sele, M. Henket, L.C. Lau, P. Bartsch, A.F. Walls, and R. Djukanovic Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease Eur. Respir. J., August 1, 2002; 20(2): 325 - 331. [Abstract] [Full Text] [PDF]

				Leader of the Working Group:, I.D. Pavord, Members of the Working Group:, P.J. Sterk, F.E. Hargreave, J.C. Kips, M.D. Inman, R. Louis, M.M.M. Pizzichini, E.H. Bel, et al. Clinical applications of assessment of airway inflammation using induced sputum Eur. Respir. J., July 1, 2002; 20(37_suppl): 40S - 43s. [Full Text] [PDF]

				R. Ottanelli, E. Rosi, I. Romagnoli, M. Grazzini, L. Stendardi, R. Duranti, and G. Scano Do Inhaled Corticosteroids Affect Perception of Dyspnea During Bronchoconstriction in Asthma? Chest, September 1, 2001; 120(3): 770 - 777. [Abstract] [Full Text] [PDF]

				A. SPANEVELLO, M. CONFALONIERI, F. SULOTTO, F. ROMANO, G. BALZANO, G. B. MIGLIORI, A. BIANCHI, and G. MICHETTI Induced Sputum Cellularity . Reference Values and Distribution in Normal Volunteers Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 1172 - 1174. [Abstract] [Full Text]

				N. M Wilson, P. Bridge, A. Spanevello, and M. Silverman Induced sputum in children: feasibility, repeatability, and relation of findings to asthma severity Thorax, September 1, 2000; 55(9): 768 - 774. [Abstract] [Full Text]

				E. Rosi and G. Scano Association of sputum parameters with clinical and functional measurements in asthma Thorax, March 1, 2000; 55(3): 235 - 238. [Full Text]

				R. LOUIS, L. C. K. LAU, A. O. BRON, A. C. ROLDAAN, and M. RADERMECKER The Relationship between Airways Inflammation and Asthma Severity Am. J. Respir. Crit. Care Med., January 1, 2000; 161(1): 9 - 16. [Abstract] [Full Text]

				C. J. HOLBERG, M. HALONEN, A. L. WRIGHT, and F. D. MARTINEZ Familial Aggregation and Segregation Analysis of Eosinophil Levels Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): 1604 - 1610. [Abstract] [Full Text]

				W. Gruber, E. Eber, A. Pfleger, M. Modl, I. Meister, E. Weinhandl, and M. S. Zach Serum Eosinophil Cationic Protein and Bronchial Responsiveness in Pediatric and Adolescent Asthma Patients Chest, August 1, 1999; 116(2): 301 - 305. [Abstract] [Full Text] [PDF]

				G. M. Moller, S. E. Overbeek, C. G. van Helden-Meeuwsen, H. C. Hoogsteden, and J. M. Bogaard Eosinophils in the bronchial mucosa in relation to methacholine dose-response curves in atopic asthma J Appl Physiol, April 1, 1999; 86(4): 1352 - 1356. [Abstract] [Full Text] [PDF]

				R G Stirling, S A Kharitonov, D Campbell, D S Robinson, S R Durham, K F Chung, and P J Barnes Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids Thorax, December 1, 1998; 53(12): 1030 - 1034. [Abstract] [Full Text]

				I. HORVATH, L. E. DONNELLY, A. KISS, S. A. KHARITONOV, S. LIM, K. FAN CHUNG, and P. J. BARNES Combined Use of Exhaled Hydrogen Peroxide and Nitric Oxide in Monitoring Asthma Am. J. Respir. Crit. Care Med., October 1, 1998; 158(4): 1042 - 1046. [Abstract] [Full Text] [PDF]